Monday, 09 Dec 2019

You are here

The RheumNow Week in Review - 8 December 2017

Dr. Jack Cush covers the news and journal articles published on RheumNow.comin the past week.

  1. Systematic review of ULT discontinuation - 5 studies shows that ULT D/C has good short term outcomes (esp if SUA is low) but delayed relapse rates occcuring 1-4.5 yrs later - more in gout (36-81%), less w/ urolithiasis (15%). https://t.co/RTIwuH154S
  2. Prospective study of 133 IBD pts (64% CD, 36% UC) switched from Remicade to biosimilar Inflectra. After 12 mos. no differences in drug levels, disease activity between innovator and biosimilar. https://t.co/QEH3lUaXD4
  3. FDA grants orphan drug designation to SER-287 a microbiome drug to treat dysbiosis of pediatric ulcerative colitis. Will microbiome targeted therapies be the next (safe) best thing? https://t.co/PmOLeyLyy3     
  4. Patients with autoimmune connective tissue diseases (CTDs) undergoing abdominoplasty are at higher risk for certain complications (hematomas, venous thromboembolism, need for transfustions and longer hospital stays) https://t.co/AXLKNg0ag2
  5. Coffee consumption (3-4cups/day) assoc w/ 17% reduction in all cause mortality, 19% for CV mortality, 18% lower Cancer risk; but in pregnancy, high versus low/no consumption was associated with 30% increase in low birth weight and pregnancy loss (OR 1.46). https://buff.ly/2iNa7M0
  6. TWO simple tests to diagnose #Fibromyalgia in primary care: 1) for tenderness to digital pressure at 10 body sites; 2)  single question, “I have a persistent deepaching over most of my body” (0–10)  https://buff.ly/2iIx03s
  7. 2005-20014 - prevalence of one comorbidity assoc w/ pregnancy & delivery increased 50% (66.9 to 91.8 per 1,000 delivery hosp.) in the USA. The frequency of multiple chronic conditions doubled ( 4.7 to 8.1/1000 delivery) during this sameperiod. https://buff.ly/2iNuDMx
  8. Infliximab Does Not Increase Perioperative Infection 
  9. Ixekizumab (Taltz) FDA Approved for Psoriatic Arthritis 
  10. Do JAK Inhibitors Increase the Risk of Venous Thromboembolic Events? 
  11. Why TNF Inhibitors May Work in Some Autoinflammatory Patients 

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

RheumNow Podcast - Monitoring Methotrexate Safety (12-6-19)

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

#WomenInRheumatology: Is There a Speaker Gender Gap at ACR Meetings?

Recent studies have quantified the gender gap among speakers at academic conferences. The largest study of 181 medical conferences held in North America over one decade found an increase in the proportion of female speakers from 25 to 34% over time, and that the underrepresentation of women was more marked at surgical compared to medical conferences.

RheumNow Podcast –Favorites of ACR 2019 (11.22.19)

Dr. Jack Cush recaps standout presentations and information from ACR 2019 held in Atlanta November 9-12, 2019.

Hepatitis C-Related Cryoglobulinemic Vasculitis

Flares of vasculitis can still be a problem after hepatitis C-related cryoglobulinemic vasculitis patients are cured of their hepatitis C by direct-acting antivirals, as demonstrated by data from four registries presented at ACR 2019 in Atlanta, Georgia.

ACR 2019 - Report from Day One (Sunday)

Sunday was the first full day of scientific sessions at the 2019 ACR/ARP meeting in Atlanta. Yesterday we shared our initial news articles, videos and more with you. Following is my roundup of day one. 

Delays in Diagnosis